Black AIDS Institute and CDC leaders finalize grant details for African American HIV University

Leaders from the Black AIDS Institute and the Centers for Disease Control and Prevention (CDC) met recently to finalize the details of a four and one-half year grant to fund the Institute's African American HIV University (AAHU) Community Mobilization College.

The AAHU Community Mobilization College is a comprehensive training and internship fellowship program aimed at strengthening organizational and individual capacity to address the HIV/AIDS epidemic in Black communities. The program is designed to decrease stigma and misperception and increase the engagement of the Black community in HIV prevention and treatment services. This is achieved through leadership development and information transfer among key stakeholders.

Using the AAHU Community Mobilization Model as a foundation, the CMC curriculum prepares community-based and AIDS service organizations to engage traditional Black institutions such as churches, civil rights and social organizations, Black political leaders, sororities/fraternities, academia and the Black media in local strategies to fight HIV. The CMC uses a unique method for exploring the complex issues and barriers that prevent many in the Black community from using HIV prevention services.

Since 2000, the Black AIDS Institute has graduated more than 50 AAHU Fellows from around the United States and Africa. The next class is expected to be enrolling in early 2010.

SOURCE Black AIDS Institute


  1. Julian Lieb,M.D Julian Lieb,M.D United States says:

    Stimulating defective immune function to perform efficiently is the logical approach to defeating pathogens. Such stimulation is propagandized as unavailable, while in reality the potent immunostimulating properties of lithium and antidepressants were documented in 1981, when I published the first of nine reviews on the topic. A therapeutic claim is reinforced when the mechanism is known. In this case, minute molecules known as prostaglandins, when produced excessively, depress every component of immune function, and induce microbial replication. In the early nineteen seventies, my late colleague David Horrobin and others showed that antidepressants and lithium inhibit prostaglandins. In a review published in 1983, I proposed that to stimulate immune function, an agent must have mood elevating properties.

    Lithium has immunostimulating, antiviral and antibacterial properties, antidepressants immunostimulating, antiviral, antibacterial, antiparasite, and fungicidal properties. Lithium is often effective for paronychia, chalazions, bacterial skin infections, urinary tract infections, canker sores, cold sores and genital herpes, antidepressants for canker sores, cold sores, genital herpes, T.B, and probably malaria and HIV. When antidepressants are added to antiretrovirals, they reduce HIV viral load to undetectable. Both lithium and antidepressants prevent recurrences of flu’ like colds, thus both could be effective for HINI. Lithium has untapped potential in methicillin-resistant staphylococcal infections, (MRSA) hospital acquired infections (HAIs) sepsis, and pressure ulcers (bed sores).

    With the threats posed by HINI, resistant T.B and the emerging resistance of the malaria parasite to artemisin, the availability of immunostimulation becomes all the more crucial. Both lithium and antidepressants prevent recurrences of flu’ like colds, thus one cannot be sure which to favor for HINI, the answer emerging were these agents used for the stricken. A few doses of lithium or an antidepressant could sufficiently stimulate immune function, and reduce viral replication, as to help some of the ailing recover.  
    The contents of this comment may be verified by searching databases. Given the perils, one should question the motives of diehards insisting on, “Large scale randomized clinical trials” or “epidemiological studies.” Release of my book, “Stimulating immune function to kill viruses” is imminent.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Canadian researchers aim to reduce chronic inflammation and comorbidities in HIV patients